Akwahosan ho nhyehyɛe pii wɔ hɔ ma obi a wanya kokoram wɔ ne berɛmo mu, a egyina ne yareɛ no so ne sɛnea ne yareɛ no mu yɛ den fa.
Ayaresa bi a wɔtaa de ma ne:
1. Ahwɛ a wɔyɛ no ntɛmntɛm: Saa kwan yi hwehwɛ sɛ wɔde ahwɛyiye hwɛ kokoram no yiye denam nhwehwɛmu a wɔyɛ no daa so, sen sɛ wɔbɛhyɛ ase asa no yare ntɛm ara.
Ebetumi ayɛ nea ɛfata ama mmarima a wɔwɔ ahoɔmmerɛw mu kokoram a enni mu pii.
2. oprehyɛn: oprehyɛn a wɔde yi ahoɔhyewa no.
Wobetumi ayɛ no oprehyɛn a wɔmmue anaa laparoscopically (wɔde nnwinnade soronko twa ade ketewa bi).
3. Radiation therapy: Saa ayaresa yi de anyinam ahoɔden a ano yɛ den di dwuma de kum kokoram nkwammoaa.
Wobetumi de ama wɔ abɔnten (efi afiri a ɛwɔ nipadua no akyi) anaa wɔ nipadua no mu (nam nneɛma a wɔde hyɛ kokoram no mu so).
4. Aduru a wɔde ma mmea a wonya ahoɔmmerɛw: Saa aduru yi ma mmarima ahoɔmmerɛw (androgens) so tew wɔ nipadua no mu, na ebetumi ama ahoɔmmerɛw mu kokoram no anyin ntɛmntɛm anaa agyae.
Wobetumi de di dwuma nkutoo anaa wɔ ka ho wɔ ayaresa afoforo mu.
5. Chemotherapy: Saa ayaresa yi de nnuru di dwuma de kum kokoram nkwammoaa.
Wobetumi de adi dwuma wɔ obi a wanya kokoram a ɛtrɛ akɔ nipadua no fa bi no ho.
6. Akwahosan a wɔde ko tia nyarewa: Saa ayaresa yi boa nipadua no ma ko tia kokoram.
Wobetumi de adi dwuma wɔ mprɔstɛt mu kokoram a ɛrekɔ n'anim a enni ayaresa afoforo ho dwuma.
7. Aduru a wɔde di dwuma titiriw: Saa aduru yi de di dwuma titiriw wɔ awosu anaa protein ahorow bi a ɛboa ma kokoram nkwammoaa nyin na ɛtra hɔ.
Wobetumi de adi dwuma wɔ mprɔstɛt mu kokoram a ɛrekɔ n'anim a enni ayaresa afoforo ho dwuma.
8. Cryotherapy: Saa ayaresa yi de awɔw a emu yɛ den na ɛyɛ adwuma de ma kokoram nkwammoaa nwini na ekum wɔn.
Wobetumi de adi dwuma wɔ ahoɔmmerɛw mu kokoram a ɛwɔ ne mfiase anaa kokoram a asan ayi ne ho adi wɔ ayaresa afoforo akyi.
9. High-intensity focused ultrasound (HIFU): Saa ayaresa yi de nnyigyei a ano yɛ den na ɛyɛ adwuma de hyew nkwammoaa a ekunkum kokoram.
Wobetumi de adi dwuma wɔ ahoɔmmerɛw mu kokoram a ɛwɔ ne mfiase anaa kokoram a asan ayi ne ho adi wɔ ayaresa afoforo akyi.
10. Hwɛ a wɔbɛhwɛ: Saa kwan yi hwehwɛ sɛ wɔde ahwɛyiye hwɛ kokoram no yiye denam nhwehwɛmu a wɔyɛ no daa so, nanso wɔmfa ayaresa no nhyɛ ase gye sɛ nsɛnkyerɛnne no da adi anaa ɛsesa.
Ebetumi ayɛ papa ama mmarima a wɔn mfe akɔ anim a wɔwɔ kokoram a enyin ntɛmntɛm ne nyarewa foforo a emu yɛ den.
Ɛho hia sɛ wo ne ayaresa kuw no susuw ayaresa ho nhyehyɛe nyinaa ho na ama wɔahu nea eye ma wo wɔ tebea biara mu.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['Abɔdin: ayaresa']
['Wɔayɛ wɛbsaet yi sɛ wɔmfa nkyerɛkyerɛ na wɔnka ho asɛm kɛkɛ, na ɛnyɛ sɛ wɔde ayaresa ho afotu anaa adwumakuw bi mmoa rema.']
['Ɛnsɛ sɛ wɔde nsɛm a wɔde ama no di dwuma de hwehwɛ yare anaa yare bi ho ayaresa, na ɛsɛ sɛ wɔn a wɔrehwehwɛ ayaresa ho afotu no ne oduruyɛfo a ɔwɔ tumi krataa di nkitaho.']
['Yɛsrɛ wo hyɛ no nsow sɛ amemene no mu mfiri a ɛma nsɛmmisa ho mmuae no nyɛ pɛpɛɛpɛ bere a ɛfa akontaahyɛde ho no. Sɛ nhwɛso no, nnipa dodow a wɔanya yare pɔtee bi.']
["Hwehwɛ afotu fi wo dɔkota anaa ayaresafo a wɔfata hɔ bere biara wɔ yareɛ ho. Nnyae ayaresa ho afotuo a wɔn a wɔn ho akokwaw de ma no ho adwenemu anaa twentwɛn wo nan ase sɛ worebɛhwehwɛ esiane biribi a woakenkan wɔ wɛbsaet yi so nti. Sɛ ɛyɛ wo sɛ wowɔ yareɛ ho nsɛmmisa a, frɛ 911 anaa kɔ ayaresabea a ɛbɛn wo pɛɛ ntɛm ara. Saa wɛbsaet yi anaa dwuma a wode di no mma wonnya oduruyɛfo ne ɔyarefo ayɔnkofa biara. BioMedLib anaa n'adwumayɛfoɔ anaa obiara a ɔde ne ho bɔ wɛbsaet yi ho dawuro biara nni mu, a ɛkyerɛ anaa enni mu, fa nsɛm a wɔde ama wɔ ha anaa dwuma a wɔde di no ho."]
['Disclaimer: copyright']
["Digital Millennium Copyright Act a w'atwe no afe 1998 wɔ U.S. Mmara 17 § 512 (DMCA) no ma wɔn a w'wɔ tumi sɛ wɔtwe wɔn ho fi nneɛma a wɔde agu intanɛt so ho kwan."]
['Sɛ wogye di sɛ wo nsɛm anaa nneɛma bi a ɛwɔ yɛn wɛbsaet anaa yɛn dwumadie mu no to wo mmara a woahyehyɛ no so a, wo (anaa wo dwumadifoɔ) bɛtumi de nkaebɔ ama yɛn de apɛ sɛ yɛyi nsɛm anaa nneɛma no firi hɔ anaa yɛsi ho kwan.']
["Ɛsɛ sɛ wɔde nkaebɔ fa e-mail so kɔma wɔn (hwɛ 'Contact' section ma e-mail address)."]
['DMCA hwehwɛ sɛ wo dawurubɔ a ɛfa mmara a obi abu so ho no de nsɛm a edidi so yi ka ho: (1) nkyerɛwde a ɛkyerɛ adwuma a mmara bɔ ho ban a obi abu so no; (2) nsɛm a wɔkyerɛ sɛ obi abu so no ne ɛho nsɛm a ɛfata a ɛbɛma yɛahunu faako a saa nsɛm no wɔ; (3) wo nkitahodi ho nsɛm, a wo address, fon number ne email ka ho; (4) krataa a woakyerɛ sɛ wowɔ gyidie pa sɛ nea woabɔ ho dawuru no nni mmara no wura anaa nea ɔhwɛ so anaa mmara biara tumi mu.']
['(5) sɛ wo de wo nsa ahyɛ krataa ase, na wohyɛ sɛ wobedi atoro, sɛ nsɛm a ɛwɔ krataa no mu yɛ nokware, na wowɔ tumi sɛ wode wo nsa bɛka nneɛma a obi akyerɛw abrɛ wo ase no;']
["و (6) physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner's behalf."]
['Sɛ woantwerɛ nsɛm a ɛwɔ soro yi nyinaa amfiri wo nkrataa no mu a, ɛbɛtumi ama wo kyɛfa no akyɛ.']
['Nkitahodi']
['Yɛsrɛ wo, fa nsɛmmisa anaa nyansahyɛ biara fa e-mail so brɛ yɛn.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Ɛfa ho']
['BioMedLib de kɔmputa a ɛyɛ adwuma ankasa (fidie a wɔde sua ade) na ɛyɛ nsɛmmisa ne mmuae.']
['Yɛde yɛn afi ayaresa ho nhoma ɔpepem 35 a ɛwɔ PubMed/Medline ase. Afei nso, RefinedWeb wɛb nkratafa.']
